Skip to main content
Caplight Logo









Airway Therapeutics

Airway Therapeutics

Private
Marietta, GeorgiaHealthcare & Life Scienceshttps://www.airwaytherapeutics.com/

Last Round

Series E

Extension

Aug 25, 2026

Total Funding Raised

$81.1M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Airway Therapeutics is a biopharmaceutical company developing a new class of biologic therapies to prevent and treat respiratory, inflammatory, and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalbiotechprotein therapeuticsrespiratory diseasesurfactant protein DSP-Dlung inflammationbiologicsclinical-stage biotechneonatologycritical care pulmonologydrug developmentrecombinant proteinpharma pipelinedrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Airway Therapeutics Comparables

Compare Airway Therapeutics with similar companies based on industry and business-model similarity.

Airway Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EXO Biologics
86%
Oak Hill Bio
80%
ONY Biotech
79%

Airway Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series E ExtensionAug 25, 2026
Series CJan 8, 2020
Series BApr 17, 2018
VC RoundMar 6, 2017
Series ASep 10, 2014
Seed
Jun 1, 2011

Airway Therapeutics Investors

Notable investors and investment history

Airway Therapeutics investors
InvestorRounds
QCA VenturesSeries A, Series B
QCA VenturesVC Round, Series A, Series B, Series C
Ohio Third FrontierSeries C
CincyTechVC Round, Series A, Seed, Series B, Series C
CincyTechSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2026

    $50M round with Cincinnati Children's participation.

  • Jul 26, 2026

    Monthly visitors grew 39% MoM, from 763 to 1.1K.

Airway Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Airway Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Airway Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarietta, Georgia
Employee Range16
Year Founded2011
Last FundingAug 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?